Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Operating Expenses (2016 - 2025)

CorMedix's Operating Expenses history spans 13 years, with the latest figure at $48.2 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 181.79% year-over-year to $48.2 million; the TTM value through Dec 2025 reached $125.6 million, up 130.05%, while the annual FY2025 figure was $125.6 million, 100.53% up from the prior year.
  • Operating Expenses for Q4 2025 was $48.2 million at CorMedix, up from $41.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $48.2 million in Q4 2025 and bottomed at $5.9 million in Q2 2021.
  • The 5-year median for Operating Expenses is $10.5 million (2023), against an average of $14.4 million.
  • The largest annual shift saw Operating Expenses crashed 35.96% in 2024 before it soared 196.9% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $7.8 million in 2021, then increased by 8.09% to $8.4 million in 2022, then increased by 24.34% to $10.5 million in 2023, then surged by 63.35% to $17.1 million in 2024, then skyrocketed by 181.79% to $48.2 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Operating Expenses are $48.2 million (Q4 2025), $41.7 million (Q3 2025), and $18.3 million (Q2 2025).